The two products can appear identical in a technical data sheet. Both are two-component epoxy systems. Both list lap shear strength, viscosity, cure schedule, and service temperature. Both cure to a hard, rigid bond. The difference that matters — the difference that determines whether a device regulatory submission succeeds or fails, whether a manufacturing lot is releasable or quarantined, and whether a patient contact device is safe or a liability — does not appear prominently in performance data. It is embedded in the raw material selection, the testing program, the documentation structure, and the quality system behind the product. Substituting industrial epoxy for medical-grade in a regulated device application is not a cost-saving decision — it is a risk transfer onto the device manufacturer.

Formulation Differences: What Is in the Product

Medical-grade and industrial epoxy adhesives can share the same base resin chemistry — bisphenol-A diglycidyl ether, bisphenol-F resin, or cycloaliphatic epoxy — but differ in the supporting chemistry selected for the specific formulation purpose.

Industrial formulations prioritize performance metrics — maximum bond strength, viscosity, working life, and cure speed — with raw materials selected for cost and availability within those performance constraints. A reactive diluent that reduces viscosity and costs 20 percent less than its alternative may be chosen for an industrial product without regard to its extractability in aqueous environments or its cytotoxic potential.

Medical formulations use the same performance criteria but add patient-safety constraints on raw material selection. Every component of the formulation — resin, hardener, accelerator, diluent, filler, and pigment — is evaluated against known biocompatibility data. Materials with known cytotoxicity, sensitization potential, or problematic leachable chemistry are excluded or used only at concentrations demonstrated to be safe. Functional raw material choices are made with both performance and safety in mind.

The result is often a formulation that performs similarly to an industrial product on mechanical property data sheets but has fundamentally different chemistry in the portions of the formulation that matter for patient safety — the hardener residuals, the diluent identity, and the catalyst system.

Testing Differences: What Data Exists

Industrial adhesives are tested for adhesion, strength, temperature resistance, chemical resistance, and shelf life. This is the complete testing program for a product intended for structural assembly of machines, vehicles, and equipment where patient contact is not a consideration.

Medical-grade epoxy carries all of that testing plus a biological evaluation data package: ISO 10993-5 cytotoxicity, ISO 10993-10 sensitization, and depending on the contact category, irritation, systemic toxicity, and extractables data. This testing is performed on the cured adhesive at the specified cure schedule, by an accredited biological testing laboratory, and reported in a format that can be referenced in a device regulatory submission.

The testing requirement is not just about having a piece of paper — it is about having tested the actual product at the actual cure conditions used in device manufacturing. An industrial epoxy tested ad hoc by a contract laboratory at conditions different from the device production cure is not equivalent to a medical-grade product with a validated biocompatibility package at the production cure schedule. If the cure schedule changes or the batch composition shifts within specification, the testing may no longer represent the actual product the patient is exposed to.

For ISO 10993 data packages for specific Incure medical-grade formulations, Email Us — Incure can provide complete biocompatibility documentation for regulatory submissions.

Documentation Differences: What Is Available

Medical device manufacturers under ISO 13485 quality systems are required to maintain documented evidence that materials used in device production meet the requirements of the device design specification. For adhesives, this means having, on file, documentation that the specific adhesive lot used in each production batch has been characterized, tested, and verified against the device design requirements.

Medical-grade epoxy suppliers maintain a documentation package for each product: specification sheets with acceptance criteria and test methods, certificate of analysis for each manufacturing lot confirming tested properties against specifications, biocompatibility summary linking test reports to the product, and shelf life documentation with storage conditions and expiration.

Industrial adhesive suppliers provide a product data sheet and a safety data sheet. Lot-specific certificates of analysis are available only for some products and may cover only physical properties rather than the chemical identity and purity information relevant to biocompatibility. The documentation structure needed for ISO 13485 traceability does not exist as a standard deliverable from industrial adhesive suppliers.

Why the Substitution Fails in Practice

Device manufacturers who use industrial adhesives in regulated applications face predictable problems at predictable points in the product lifecycle.

At regulatory submission: The device biological evaluation report requires a biocompatibility data reference for every patient-contact material. If the adhesive has no ISO 10993 data, the data must be generated — at the cost and time of a full biocompatibility testing program. The device submission is blocked until this data exists.

At manufacturing release: ISO 13485 procedures require lot traceability. Without a certificate of analysis from the adhesive supplier covering the lot used in production, the production record is incomplete, and a quality auditor or regulatory inspector can cite the device manufacturer for failure to control materials.

At post-market surveillance: If a patient safety issue arises and the regulatory authority asks for the material composition and biocompatibility data for every component in the device, an industrial adhesive without documentation creates a gap in the response that cannot be easily filled after the fact.

Contact Our Team to discuss medical-grade epoxy product selection, biocompatibility documentation, and lot traceability for your device manufacturing program.

Visit www.incurelab.com for more information.